Jaeyeon Kim
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 31
- CAR-T cell therapy research 21
- Cancer Immunotherapy and Biomarkers 7
-
- Renal and related cancers 8
- Co-authors
- Peter C. Brooks (3 shared papers)Jingsong Xu (3 shared papers)Masanori Hangai (2 shared papers)Éric Petitclerc (1 shared paper)George E. Davis (1 shared paper)Samuel Yuen (1 shared paper)Brian I. Rini (6 shared papers)Jason Chesney (3 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Blood (10 papers)physica status solidi (a) (3 papers)Scientific Reports (2 papers)Journal of the American Pharmacists Association (2 papers)
- Partner nations
- United StatesSouth KoreaCanada
In The Last Decade
Jaeyeon Kim
82 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 563
- Oncology 985
- Immunology and Allergy 218
- Pulmonary and Respiratory Medicine 632
- Immunology 319
Countries citing papers authored by Jaeyeon Kim
This map shows the geographic impact of Jaeyeon Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaeyeon Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaeyeon Kim more than expected).
Fields of papers citing papers by Jaeyeon Kim
This network shows the impact of papers produced by Jaeyeon Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaeyeon Kim. The network helps show where Jaeyeon Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside Jaeyeon Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma Hit paper breakdown → | 2017 | 471 |
| 2 | 2001 | 375 | |
| 3 | 2014 | 311 | |
| 4 | 2011 | 107 | |
| 5 | 2011 | 103 | |
| 6 | 2002 | 98 | |
| 7 | 2011 | 65 | |
| 8 | 2019 | 51 | |
| 9 | 2014 | 51 | |
| 10 | 2000 | 47 | |
| 11 | 2021 | 45 | |
| 12 | 2010 | 42 | |
| 13 | 2020 | 33 | |
| 14 | 2022 | 32 | |
| 15 | 2017 | 31 | |
| 16 | 2012 | 27 | |
| 17 | 2020 | 26 | |
| 18 | 2014 | 24 | |
| 19 | 2011 | 24 | |
| 20 | 2010 | 22 |
About Jaeyeon Kim
Jaeyeon Kim is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Electrical and Electronic Engineering and Cancer Research, having authored 90 papers that have together received 2.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (21 papers), Renal cell carcinoma treatment (14 papers), Advanced Memory and Neural Computing (11 papers), Renal and related cancers (8 papers), Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Phase-change materials and chalcogenides (7 papers) and Stellar, planetary, and galactic studies (6 papers). The work is most often cited by research in Cancer Research (563 citations), Oncology (985 citations), Immunology and Allergy (218 citations), Pulmonary and Respiratory Medicine (632 citations) and Immunology (319 citations). Jaeyeon Kim has collaborated with scholars based in United States, South Korea and Canada. Frequent co-authors include Peter C. Brooks, Jingsong Xu, Masanori Hangai, Éric Petitclerc, George E. Davis, Samuel Yuen, Brian I. Rini, Jason Chesney, Mohammed Milhem and Claus Garbe. Their work appears in journals such as Journal of Clinical Oncology, Blood, physica status solidi (a), Scientific Reports and Journal of the American Pharmacists Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.